Company profile
Cann American Corp.
OTC: CNNA · Healthcare · Drug Manufacturers - Specialty & Generic
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 34
v0.1 · 5/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ workforce scale, filing timeliness
Methodology →Revenue TTM
$21
Rev growth YoY (TTM)
-64.9%
Net income (FY)
-$1.7M
Employees
1
as of 2026-08-24
Market cap
$3.7M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$1.7M-$1.7M2011
Operating income-$2.0M-$2.0M2011
Total assets$1.2M$1.2M2011
Equity$904.4k$904.4k2011
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Cann American Corp.’s financial profile?
Cann American Corp. earned -$1.7M in FY2011 net income.
Peers · Healthcare
LianBio——Revelation Biosciences, Inc.——KMA Holding, Inc.——CTT Pharmaceutical Holdings, Inc.——MetaVia Inc.——Standard Dental Labs Inc.——Neighbors
Sonoma →Key facts
CEOJason R. Tucker
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersCloverdale, CA
ExchangeOTC: CNNA
Employees1
IPO date2011-02-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.